Cytomed Therapeutics shares owned by UBS Group
Quarter-by-quarter ownership of Cytomed Therapeutics (GDTC) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Cytomed Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Cytomed Therapeutics held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Cytomed Therapeutics by UBS Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $26k | 13k | 1.99 |
| 2025-06-30 | $40k | 18k | 2.25 |
| 2025-03-31 | $32k | 14k | 2.18 |
| 2024-12-31 | $34k | 10k | 3.40 |
| 2024-09-30 | $96 | 61 | 1.57 |
| 2023-12-31 | $17k | 3.5k | 4.90 |
| 2023-09-30 | $1.7k | 477 | 3.50 |
| 2023-06-30 | $165 | 54 | 3.06 |
Top funds holding Cytomed Therapeutics
View all funds holding Cytomed Therapeutics